Employees Area
Management Profiles

M. Jawed Akhai is a prominent businessman in the pharmaceutical sector. He belongs to a family engaged in pharmaceutical business for over five decades. Currently he holds the position of Chairman at Martin Dow Ltd. Exhibiting inspiring innovativeness and entrepreneurial skills, Jawed Akhai acquired the pharmaceutical manufacturing plant along with the brands of F. Hoffmann-La Roche (Switzerland) in Pakistan and licensing of some of their top line products, which is one of the largest acquisitions in the pharmaceutical industry of Pakistan. Mr. Jawed is a Business Graduate from Institute of Business Administration (IBA). Besides being the Chairman of Martin Dow, he holds many positions with different associations including Former Chairman of Pakistan Pharmaceutical Manufacturer’s Association (PPMA), associate member of FPCCI Trade Body for Pharma Sector, Director of Pakistan-USA business Council of FPCCI, member of Swiss Business Council, member of Pakistan France Business Alliance, member of Karachi Chamber of Commerce & Industry, member of Marketing Association of Pakistan and President of COMMECS (The Old Students Association of Govt. College of Commerce & Economics). At Martin Dow, Jawed is involved in setting the strategic business direction of senior management along with the quest of operational excellence. In addition, Jawed is actively involved in philanthropic activities with the social sector. His main focus is on development of Health & Education segments.

Mr. Mohammad Amjad brings with him vast experience of 35 years in pharmaceutical manufacturing and plant operations with leading companies like Wyeth and Sanofi. Before joining Martin Dow, Mr. Mohammad Amjad served OBS Pakistan as Director Industrial Operations. He holds a Bachelor of Science degree in Industrial Engineering from California State Polytechnic University and MBA from University of La Verne, USA. At Martin Dow, Mr. Mohammad Amjad is leading Technical Operations of Karachi SITE and Seatle – Lahore SITE that includes Production, New Product Development, Regulatory Affairs, Engineering & Projects.

Muqtadir Jawad has been associated with Martin Dow since 2001. With a diversified experience of more than 29 years in the pharmaceutical industry, engaged in matters of supply chain, taxation and corporate affairs, Muqtadir Jawad has gyrated Martin Dow to the level of alacrity. His strong interpersonal skills are an assurance of ascent to newer horizons for the company.

Rizwan Omar is a senior Human Resources professional with 29 years of broad-based functional business experience in the manufacturing and service industry. For the initial period of 18 years, Rizwan served Bristol-Myers Squibb and has also worked for various local pharmaceutical companies of repute. His inherently driven strategies have played a key role in enhancing organizational capability, performance, commitment and results. His rich experience in human resources and his business acumen make him capable of delivering high quality results and the culture of teamwork and productivity in the organization.

Mr. Ali Aamir brings with him a total of over 30 years of varied experience. He has worked in senior positions with local as well as multinational organizations, adding depth and scale to his knowledge and experience. These include A. F. Ferguson & Co, ANZ Grindlays Bank, ICI Pakistan Limited, Lotte Pakistan PTA Limited, Dawood Hercules Corporation Limited and a brief stint at Herbion Pakistan (Pvt) Limited . Mr. Ali Aamir is a fellow member of the Institute of Chartered Accountants of Pakistan and Associate Member of the Institute of Chartered Accountants in England & Wales. At Martin Dow, Mr. Ali Aamir is looking after the Finance, Information Technology & Commercial functions.

Mr. Rustom J. Boga brings with him a total of over 30 years of comprehensive knowledge and varied experience of marketing and communications. He has been associated with both national and multinational organizations including Unilever, Standard Chartered, Cupola and Manhattan International. He holds a Master of Business Administration (MBA) degree with majors in Marketing from IBA. At Martin Dow, Mr. Rustom J.Boga is responsible for managing all corporate communications of the Group alongside aligning internal communication activities associated with brands activation/promotional campaigns. He is also be responsible for keeping & sustaining relations with both print and electronic media to enhance Group image.

Dr. Farrukh Hafeez has an extensive experience of over 30 years in Pharmaceutical Plant and Quality Operations. He holds a Ph.D. degree in Organic Chemistry from HEJ Research Institute, Karachi. Before becoming a part of Martin Dow, he was affiliated with Abbott Laboratories in the capacity of Director Quality Assurance for over 13 years and was also associated with Searle & Barrett Hodgson on various senior positions. He is the originator of more than 25 research papers which have been published in numerous international journals. Quality Assurance, Quality Control, GMP Compliance and Technical Services of Martin Dow Ltd. – Karachi & Seatle – Lahore sites and overseeing Quality Operations of Meymac & Gien sites will be under his leadership at Martin Dow.

Mr. Shaikh Muhammad Inam graduated from University of Karachi in 2002 with Bachelor of Pharmacy degree. He brings varied experience of Quality Operations from MNCs including Pfizer, Barret Hodgson and Sanofi. Mr. Inam secured a Gold Medal at Merck Pakistan for his extraordinary services. His area of expertise includes Regulatory matters of local and international market, Global Quality Systems, global and local compliance, audits and training of employees.

Facebook

News & Media

  • Top Pharmaceutical Companies Supplement
    Top Pharmaceutical Companies Supplement
    (October 26, 2017)

    Read More
  • The Swiss Confederation Day Supplement
    The Swiss Confederation Day Supplement
    (October 26, 2017)

    Read More
  • Bastille Day Supplement
    Bastille Day Supplement
    (October 26, 2017)

    Read More
  • Martin Dow announces the National Consensus Guidelines for Chemoprophylaxis & Surgical Site Infections
    Martin Dow announces the National Consensus Guidelines for Chemoprophylaxis & Surgical Site Infections
    (August 3, 2017)

    Read More
  • Martin Dow in talks to buy French biotech firm
    Martin Dow in talks to buy French biotech firm
    (April 12, 2017)

    Read More
  • Martin Dow Pharmaceuticals Inauguration : Meymac France
    Martin Dow Pharmaceuticals Inauguration : Meymac France
    (March 24, 2017)

    Read More
  • World Osteoporosis Day Radio Program
    World Osteoporosis Day Radio Program
    (February 6, 2017)

    Read More
  • Martin Dow-Biocodex to supply Enflor
    Martin Dow-Biocodex to supply Enflor
    (January 18, 2017)

    Read More
  • TerraBiz to hold first M&A moot on December 7
    TerraBiz to hold first M&A moot on December 7
    (January 18, 2017)

    Read More
  • French President to inaugurate Pakistani Pharma Plant in France
    French President to inaugurate Pakistani Pharma Plant in France
    (January 18, 2017)

    Read More
  • Martin Dow acquires Merck operations in Pakistan
    Martin Dow acquires Merck operations in Pakistan
    (January 18, 2017)

    Read More
  • World Mental Health Day
    World Mental Health Day
    (December 22, 2016)

    Read More
  • France Trade & Investment Report 2016
    France Trade & Investment Report 2016
    (July 14, 2016)

    Read More
  • Serving the changing world
    Serving the changing world
    (November 16, 2015)

    Read More
  • Martin Dow setting up clinic for IBA students
    Martin Dow setting up clinic for IBA students
    (November 14, 2015)

    Read More
  • Awarding Dr. Ishrat Hussain
    Awarding Dr. Ishrat Hussain
    (August 31, 2015)

    Read More
  • Martin Dow and quality healthcare go together
    Martin Dow and quality healthcare go together
    (July 14, 2015)

    Read More
  • Martin Dow donates Rs 1 million to IBA
    Martin Dow donates Rs 1 million to IBA
    (April 4, 2015)

    Read More
  • MD Biocodex sign deal
    MD Biocodex sign deal
    (February 26, 2015)

    Read More